{"id":29871,"date":"2012-08-02T14:52:22","date_gmt":"2012-08-02T18:52:22","guid":{"rendered":"http:\/\/asweetlife.org\/?p=28724"},"modified":"2016-09-25T05:06:09","modified_gmt":"2016-09-25T09:06:09","slug":"positive-results-for-echos-transdermal-continuous-glucose-monitoring-system","status":"publish","type":"post","link":"https:\/\/asweetlife.org\/?p=29871","title":{"rendered":"Positive Results for Echo Therapeutics’ Transdermal Continuous Glucose Monitoring System"},"content":{"rendered":"

\"\"<\/a>Echo Therapeutics\u00a0announced positive results from its clinical trial of the Symphony tCGM System, a non-invasive, wireless, transdermal continuous glucose monitoring system<\/a>,\u00a0in major general surgery and cardiothoracic surgery patients.\u00a0 This study is the second of two studies in critically ill patients.<\/p>\n

Data from this study demonstrate that Symphony successfully and continuously monitored glucose levels in the intensive care unit at\u00a0Thomas Jefferson University\u00a0Hospital in\u00a0Philadelphia, Pennsylvania.\u00a0 Data analysis demonstrated that Symphony accurately read glucose levels with a mean absolute relative difference (MARD), or error rate of 9.0%.\u00a0 The Continuous Glucose-Error Grid analysis (CG-EGA) showed that 98.9% of the readings were clinically accurate (A) and 0.3% were benign (B) errors with a combined A+B of 99.2%<\/p>\n

“We are extremely pleased with the positive results of this trial which demonstrate that Symphony can accurately read glucose in critically ill patients who have undergone major general surgery.\u00a0 Additionally, this study demonstrates that Symphony performs consistently well in yet another patient group.\u00a0 Data from this study are very similar to patients in other studies with differing disease states,” said\u00a0Patrick T. Mooney, M.D., Chairman and CEO of Echo Therapeutics.\u00a0 “We believe, if used effectively, Symphony will help prevent hypo- and hyperglycemic excursions in patients and will improve patient outcomes.”<\/p>\n

Jeffrey I. Joseph, D.O., Professor of Anesthesiology and Director of the Jefferson Artificial Pancreas Center at\u00a0Thomas Jefferson University, and the Principal Investigator of the study, added: “The Echo Therapeutics’ continuous glucose monitoring system safely and accurately measured the\u00a0concentration of glucose in a wide variety of surgical patients managed in the ICU. Study physicians and nurses found the non-invasive, wireless continuous glucose monitoring system easy to apply and utilize in the critical care environment.\u00a0 Current methods of glucose monitoring in the hospital are intermittent, labor intensive, prone to error, and expose the caregiver to blood.\u00a0 Hospitals rarely monitor glucose frequently enough to minimize hyperglycemia and avoid hypoglycemia. Thus, there is great clinical need in the hospital for a continuous glucose monitoring system that reliably provides a real-time glucose measurement every minute or two.\u00a0 The bedside clinician will use the glucose trend information to support glycemic control protocols, leading to improved clinical outcome.\u00a0 The Echo Therapeutics’ Symphony continuous glucose monitoring system demonstrated satisfactory safety, accuracy, and reliability during the clinical trial at\u00a0Thomas Jefferson University\u00a0Hospital.”<\/p>\n

Source:\u00a0www.echotx.com<\/a><\/p>\n","protected":false},"excerpt":{"rendered":"

Echo Therapeutics announced positive results from its clinical trial of the Symphony tCGM System, a non-invasive, wireless, transdermal continuous glucose monitoring system, in major general surgery and cardiothoracic surgery patients. This study is the second of two studies in critically ill patients.
\nData from this study demonstrate that Symphony successfully and continuously monitored glucose levels in the intensive care unit at Thomas Jefferson University Hospital in Philadelphia, Pennsylvania.<\/p>\n","protected":false},"author":131,"featured_media":29929,"comment_status":"open","ping_status":"closed","sticky":false,"template":"","format":"standard","meta":{"_relevanssi_hide_post":"","_relevanssi_hide_content":"","_relevanssi_pin_for_all":"","_relevanssi_pin_keywords":"","_relevanssi_unpin_keywords":"","_relevanssi_related_keywords":"","_relevanssi_related_include_ids":"","_relevanssi_related_exclude_ids":"","_relevanssi_related_no_append":"","_relevanssi_related_not_related":"","_relevanssi_related_posts":"","_relevanssi_noindex_reason":"","footnotes":""},"categories":[1437],"tags":[115,1234],"yoast_head":"\nPositive Results for Echo Therapeutics' Transdermal Continuous Glucose Monitoring System<\/title>\n<meta name=\"description\" content=\"Echo Therapeutics announced positive results from its clinical trial of the Symphony tCGM System, a non-invasive, wireless, transdermal continuous glucose monitoring system, in major general surgery and cardiothoracic surgery patients. This study is the second of two studies in critically ill patients.\" \/>\n<meta name=\"robots\" content=\"index, follow, max-snippet:-1, max-image-preview:large, max-video-preview:-1\" \/>\n<link rel=\"canonical\" href=\"https:\/\/asweetlife.org\/?p=29871\" \/>\n<meta name=\"twitter:label1\" content=\"Written by\" \/>\n\t<meta name=\"twitter:data1\" content=\"ASweetLife Team\" \/>\n\t<meta name=\"twitter:label2\" content=\"Est. reading time\" \/>\n\t<meta name=\"twitter:data2\" content=\"2 minutes\" \/>\n<script type=\"application\/ld+json\" class=\"yoast-schema-graph\">{\"@context\":\"https:\/\/schema.org\",\"@graph\":[{\"@type\":\"WebPage\",\"@id\":\"https:\/\/asweetlife.org\/?p=29871\",\"url\":\"https:\/\/asweetlife.org\/?p=29871\",\"name\":\"Positive Results for Echo Therapeutics' Transdermal Continuous Glucose Monitoring System\",\"isPartOf\":{\"@id\":\"https:\/\/asweetlife.org\/#website\"},\"primaryImageOfPage\":{\"@id\":\"https:\/\/asweetlife.org\/?p=29871#primaryimage\"},\"image\":{\"@id\":\"https:\/\/asweetlife.org\/?p=29871#primaryimage\"},\"thumbnailUrl\":\"https:\/\/asweetlife.org\/wp-content\/uploads\/2012\/08\/ECHO-THERAPEUTICS-LOGO1.jpeg\",\"datePublished\":\"2012-08-02T18:52:22+00:00\",\"dateModified\":\"2016-09-25T09:06:09+00:00\",\"author\":{\"@id\":\"https:\/\/asweetlife.org\/#\/schema\/person\/5de2b093878b82b0ea97917f8fd72585\"},\"description\":\"Echo Therapeutics announced positive results from its clinical trial of the Symphony tCGM System, a non-invasive, wireless, transdermal continuous glucose monitoring system, in major general surgery and cardiothoracic surgery patients. This study is the second of two studies in critically ill patients.\",\"breadcrumb\":{\"@id\":\"https:\/\/asweetlife.org\/?p=29871#breadcrumb\"},\"inLanguage\":\"en-US\",\"potentialAction\":[{\"@type\":\"ReadAction\",\"target\":[\"https:\/\/asweetlife.org\/?p=29871\"]}]},{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\/\/asweetlife.org\/?p=29871#primaryimage\",\"url\":\"https:\/\/asweetlife.org\/wp-content\/uploads\/2012\/08\/ECHO-THERAPEUTICS-LOGO1.jpeg\",\"contentUrl\":\"https:\/\/asweetlife.org\/wp-content\/uploads\/2012\/08\/ECHO-THERAPEUTICS-LOGO1.jpeg\",\"width\":500,\"height\":213,\"caption\":\"Echo Therapeutics, Inc. logo.\"},{\"@type\":\"BreadcrumbList\",\"@id\":\"https:\/\/asweetlife.org\/?p=29871#breadcrumb\",\"itemListElement\":[{\"@type\":\"ListItem\",\"position\":1,\"name\":\"Home\",\"item\":\"https:\/\/asweetlife.org\/\"},{\"@type\":\"ListItem\",\"position\":2,\"name\":\"Positive Results for Echo Therapeutics’ Transdermal Continuous Glucose Monitoring System\"}]},{\"@type\":\"WebSite\",\"@id\":\"https:\/\/asweetlife.org\/#website\",\"url\":\"https:\/\/asweetlife.org\/\",\"name\":\"ASweetLife\",\"description\":\"The Diabetes Magazine\",\"potentialAction\":[{\"@type\":\"SearchAction\",\"target\":{\"@type\":\"EntryPoint\",\"urlTemplate\":\"https:\/\/asweetlife.org\/?s={search_term_string}\"},\"query-input\":\"required name=search_term_string\"}],\"inLanguage\":\"en-US\"},{\"@type\":\"Person\",\"@id\":\"https:\/\/asweetlife.org\/#\/schema\/person\/5de2b093878b82b0ea97917f8fd72585\",\"name\":\"ASweetLife Team\",\"image\":{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\/\/asweetlife.org\/#\/schema\/person\/image\/\",\"url\":\"https:\/\/secure.gravatar.com\/avatar\/ba76b5c6c27d32738b13f9a8a5cfcf02?s=96&d=mm&r=g\",\"contentUrl\":\"https:\/\/secure.gravatar.com\/avatar\/ba76b5c6c27d32738b13f9a8a5cfcf02?s=96&d=mm&r=g\",\"caption\":\"ASweetLife Team\"},\"url\":\"https:\/\/asweetlife.org\/?author=131\"}]}<\/script>\n<!-- \/ Yoast SEO Premium plugin. -->","yoast_head_json":{"title":"Positive Results for Echo Therapeutics' Transdermal Continuous Glucose Monitoring System","description":"Echo Therapeutics announced positive results from its clinical trial of the Symphony tCGM System, a non-invasive, wireless, transdermal continuous glucose monitoring system, in major general surgery and cardiothoracic surgery patients. This study is the second of two studies in critically ill patients.","robots":{"index":"index","follow":"follow","max-snippet":"max-snippet:-1","max-image-preview":"max-image-preview:large","max-video-preview":"max-video-preview:-1"},"canonical":"https:\/\/asweetlife.org\/?p=29871","twitter_misc":{"Written by":"ASweetLife Team","Est. reading time":"2 minutes"},"schema":{"@context":"https:\/\/schema.org","@graph":[{"@type":"WebPage","@id":"https:\/\/asweetlife.org\/?p=29871","url":"https:\/\/asweetlife.org\/?p=29871","name":"Positive Results for Echo Therapeutics' Transdermal Continuous Glucose Monitoring System","isPartOf":{"@id":"https:\/\/asweetlife.org\/#website"},"primaryImageOfPage":{"@id":"https:\/\/asweetlife.org\/?p=29871#primaryimage"},"image":{"@id":"https:\/\/asweetlife.org\/?p=29871#primaryimage"},"thumbnailUrl":"https:\/\/asweetlife.org\/wp-content\/uploads\/2012\/08\/ECHO-THERAPEUTICS-LOGO1.jpeg","datePublished":"2012-08-02T18:52:22+00:00","dateModified":"2016-09-25T09:06:09+00:00","author":{"@id":"https:\/\/asweetlife.org\/#\/schema\/person\/5de2b093878b82b0ea97917f8fd72585"},"description":"Echo Therapeutics announced positive results from its clinical trial of the Symphony tCGM System, a non-invasive, wireless, transdermal continuous glucose monitoring system, in major general surgery and cardiothoracic surgery patients. This study is the second of two studies in critically ill patients.","breadcrumb":{"@id":"https:\/\/asweetlife.org\/?p=29871#breadcrumb"},"inLanguage":"en-US","potentialAction":[{"@type":"ReadAction","target":["https:\/\/asweetlife.org\/?p=29871"]}]},{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/asweetlife.org\/?p=29871#primaryimage","url":"https:\/\/asweetlife.org\/wp-content\/uploads\/2012\/08\/ECHO-THERAPEUTICS-LOGO1.jpeg","contentUrl":"https:\/\/asweetlife.org\/wp-content\/uploads\/2012\/08\/ECHO-THERAPEUTICS-LOGO1.jpeg","width":500,"height":213,"caption":"Echo Therapeutics, Inc. logo."},{"@type":"BreadcrumbList","@id":"https:\/\/asweetlife.org\/?p=29871#breadcrumb","itemListElement":[{"@type":"ListItem","position":1,"name":"Home","item":"https:\/\/asweetlife.org\/"},{"@type":"ListItem","position":2,"name":"Positive Results for Echo Therapeutics’ Transdermal Continuous Glucose Monitoring System"}]},{"@type":"WebSite","@id":"https:\/\/asweetlife.org\/#website","url":"https:\/\/asweetlife.org\/","name":"ASweetLife","description":"The Diabetes Magazine","potentialAction":[{"@type":"SearchAction","target":{"@type":"EntryPoint","urlTemplate":"https:\/\/asweetlife.org\/?s={search_term_string}"},"query-input":"required name=search_term_string"}],"inLanguage":"en-US"},{"@type":"Person","@id":"https:\/\/asweetlife.org\/#\/schema\/person\/5de2b093878b82b0ea97917f8fd72585","name":"ASweetLife Team","image":{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/asweetlife.org\/#\/schema\/person\/image\/","url":"https:\/\/secure.gravatar.com\/avatar\/ba76b5c6c27d32738b13f9a8a5cfcf02?s=96&d=mm&r=g","contentUrl":"https:\/\/secure.gravatar.com\/avatar\/ba76b5c6c27d32738b13f9a8a5cfcf02?s=96&d=mm&r=g","caption":"ASweetLife Team"},"url":"https:\/\/asweetlife.org\/?author=131"}]}},"_links":{"self":[{"href":"https:\/\/asweetlife.org\/index.php?rest_route=\/wp\/v2\/posts\/29871"}],"collection":[{"href":"https:\/\/asweetlife.org\/index.php?rest_route=\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/asweetlife.org\/index.php?rest_route=\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/asweetlife.org\/index.php?rest_route=\/wp\/v2\/users\/131"}],"replies":[{"embeddable":true,"href":"https:\/\/asweetlife.org\/index.php?rest_route=%2Fwp%2Fv2%2Fcomments&post=29871"}],"version-history":[{"count":0,"href":"https:\/\/asweetlife.org\/index.php?rest_route=\/wp\/v2\/posts\/29871\/revisions"}],"wp:featuredmedia":[{"embeddable":true,"href":"https:\/\/asweetlife.org\/index.php?rest_route=\/wp\/v2\/media\/29929"}],"wp:attachment":[{"href":"https:\/\/asweetlife.org\/index.php?rest_route=%2Fwp%2Fv2%2Fmedia&parent=29871"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/asweetlife.org\/index.php?rest_route=%2Fwp%2Fv2%2Fcategories&post=29871"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/asweetlife.org\/index.php?rest_route=%2Fwp%2Fv2%2Ftags&post=29871"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}